SOFINNOVA INVESTMENTS, INC. Holdings

SOFINNOVA INVESTMENTS, INC. is an investment fund managing more than 1.72B US dollars. The largest holdings include Karuna Therapeutics, CinCor Pharma and Natera. In Q3 2022 the fund bought assets of total value of 321.51M US dollars and sold assets of total value of 120.05M US dollars.

$1.71B

portfolio value

+31.77%

quarter

-16.94%

1 year

+33.32%

3 years

SOFINNOVA INVESTMENTS, INC. portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q2 2018	134743000	97834000
Q3 2018	371019000	16053000
Q1 2019	74527000	64658000
Q2 2019	191192000	68397000
Q3 2019	114531000	105110000
Q4 2019	424240000	136699000
Q1 2020	114118000	169437000
Q2 2020	330746000	130568000
Q3 2020	161880000	275542000
Q4 2020	281889000	128040000
Q1 2021	358165000	368076000
Q2 2021	308984000	182432000
Q3 2021	197594000	239605000
Q4 2021	370988000	207684000
Q1 2022	237356000	403061000
Q2 2022	189255000	179166000
Q3 2022	321508000	120049000

SOFINNOVA INVESTMENTS, INC. 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 27.13% Portfolio value: 466.30M Avg. open price: $73.58 Current price: $236.82 P/L: +221.87% Bought +6.15% shares Q2 2022	share	27.13%	466.30M	$73.58	$236.82	+221.87%	Bought +6.15% shares Q2 2022
Biotechnology CinCor Pharma, Inc. Portfolio share: 11.61% Portfolio value: 199.54M Avg. open price: $18.84 Current price: $12.29 P/L: -34.77% Bought +9.08% shares Q3 2022	share	11.61%	199.54M	$18.84	$12.29	-34.77%	Bought +9.08% shares Q3 2022
Diagnostics & Research Natera, Inc. Portfolio share: 7.91% Portfolio value: 135.97M Avg. open price: $113.53 Current price: $41.84 P/L: -63.15% Bought +0.08% shares Q3 2021	share	7.91%	135.97M	$113.53	$41.84	-63.15%	Bought +0.08% shares Q3 2021
Biotechnology Vera Therapeutics, Inc. Portfolio share: 3.94% Portfolio value: 67.79M Avg. open price: $25.3 Current price: $16.3 P/L: -35.57% Bought +9.15% shares Q1 2022	share	3.94%	67.79M	$25.3	$16.3	-35.57%	Bought +9.15% shares Q1 2022
Biotechnology Aerovate Therapeutics, Inc. Portfolio share: 3.63% Portfolio value: 62.31M Avg. open price: N/A Current price: $18.31 P/L: N/A N/A Q2 2021	share	3.63%	62.31M	N/A	$18.31	N/A	N/A Q2 2021
Biotechnology Ascendis Pharma A/S Portfolio share: 3.00% Portfolio value: 51.61M Avg. open price: $117.47 Current price: $125.39 P/L: +6.74% Sold -4.23% shares Q3 2021	share	3.00%	51.61M	$117.47	$125.39	+6.74%	Sold -4.23% shares Q3 2021
Drug Manufacturers—General Merck & Co., Inc. Portfolio share: 2.92% Portfolio value: 50.24M Avg. open price: $86.44 Current price: $110.04 P/L: +27.30% Bought +61.64% shares Q3 2022	share	2.92%	50.24M	$86.44	$110.04	+27.30%	Bought +61.64% shares Q3 2022
Drug Manufacturers—General Sanofi Portfolio share: 2.80% Portfolio value: 48.07M Avg. open price: $50.03 Current price: $45.01 P/L: -10.03% Bought +348.10% shares Q3 2022	share	2.80%	48.07M	$50.03	$45.01	-10.03%	Bought +348.10% shares Q3 2022
Invesco QQQ Trust Portfolio share: 2.33% Portfolio value: 40.08M Avg. open price: $400.35 Current price: $292.55 P/L: -26.93% N/A Q3 2022	put	2.33%	40.08M	$400.35	$292.55	-26.93%	N/A Q3 2022
Drug Manufacturers—General AstraZeneca PLC Portfolio share: 2.24% Portfolio value: 38.49M Avg. open price: $53.67 Current price: $68.47 P/L: +27.57% Bought +121.86% shares Q3 2022	share	2.24%	38.49M	$53.67	$68.47	+27.57%	Bought +121.86% shares Q3 2022
Health Care Select Sector SPDR Fund Portfolio share: 2.11% Portfolio value: 36.33M Avg. open price: N/A Current price: $139.78 P/L: N/A N/A Q2 2022	put	2.11%	36.33M	N/A	$139.78	N/A	N/A Q2 2022
iShares Russell 2000 ETF Portfolio share: 1.92% Portfolio value: 32.98M Avg. open price: N/A Current price: $188.05 P/L: N/A N/A Q3 2022	put	1.92%	32.98M	N/A	$188.05	N/A	N/A Q3 2022
Biotechnology Y-mAbs Therapeutics, Inc. Portfolio share: 1.84% Portfolio value: 31.64M Avg. open price: $26.06 Current price: $4.24 P/L: -83.73% Bought +4.28% shares Q4 2019	share	1.84%	31.64M	$26.06	$4.24	-83.73%	Bought +4.28% shares Q4 2019
Biotechnology United Therapeutics Corporation Portfolio share: 1.80% Portfolio value: 30.89M Avg. open price: $149.11 Current price: $278.55 P/L: +86.81% Bought +38.72% shares Q3 2022	share	1.80%	30.89M	$149.11	$278.55	+86.81%	Bought +38.72% shares Q3 2022
Drug Manufacturers—General Gilead Sciences, Inc. Portfolio share: 1.73% Portfolio value: 29.75M Avg. open price: N/A Current price: $89.03 P/L: N/A N/A Q3 2022	share	1.73%	29.75M	N/A	$89.03	N/A	N/A Q3 2022
Drug Manufacturers—General Merck & Co., Inc. Portfolio share: 1.50% Portfolio value: 25.83M Avg. open price: $86.44 Current price: $110.04 P/L: +27.30% N/A Q3 2022	call	1.50%	25.83M	$86.44	$110.04	+27.30%	N/A Q3 2022
Biotechnology BioMarin Pharmaceutical Inc. Portfolio share: 1.45% Portfolio value: 24.98M Avg. open price: $86.02 Current price: $105.56 P/L: +22.71% Sold -2.27% shares Q3 2022	share	1.45%	24.98M	$86.02	$105.56	+22.71%	Sold -2.27% shares Q3 2022
Biotechnology CTI BioPharma Corp. Portfolio share: 1.22% Portfolio value: 21.02M Avg. open price: $3.84 Current price: $5.99 P/L: +55.90% Bought +33.57% shares Q3 2022	share	1.22%	21.02M	$3.84	$5.99	+55.90%	Bought +33.57% shares Q3 2022
Biotechnology Reata Pharmaceuticals, Inc. Portfolio share: 1.20% Portfolio value: 20.56M Avg. open price: $87.96 Current price: $38.98 P/L: -55.68% Bought +4.40% shares Q3 2022	share	1.20%	20.56M	$87.96	$38.98	-55.68%	Bought +4.40% shares Q3 2022
Medical Instruments & Supplies Intuitive Surgical, Inc. Portfolio share: 1.05% Portfolio value: 18.05M Avg. open price: N/A Current price: $272.25 P/L: N/A N/A Q3 2022	share	1.05%	18.05M	N/A	$272.25	N/A	N/A Q3 2022
Medical Devices iRhythm Technologies, Inc. Portfolio share: 1.02% Portfolio value: 17.55M Avg. open price: N/A Current price: $110.9 P/L: N/A Sold -1.40% shares Q3 2022	share	1.02%	17.55M	N/A	$110.9	N/A	Sold -1.40% shares Q3 2022
Medical Devices DexCom, Inc. Portfolio share: 0.97% Portfolio value: 16.58M Avg. open price: $377.41 Current price: $118.11 P/L: -68.71% Bought +8.91% shares Q3 2022	share	0.97%	16.58M	$377.41	$118.11	-68.71%	Bought +8.91% shares Q3 2022
Biotechnology Sarepta Therapeutics, Inc. Portfolio share: 0.91% Portfolio value: 15.63M Avg. open price: $100.22 Current price: $126.25 P/L: +25.97% Bought +7.77% shares Q3 2022	share	0.91%	15.63M	$100.22	$126.25	+25.97%	Bought +7.77% shares Q3 2022
Biotechnology Cytokinetics, Incorporated Portfolio share: 0.90% Portfolio value: 15.53M Avg. open price: $28.38 Current price: $40.49 P/L: +42.66% Sold -0.02% shares Q3 2022	share	0.90%	15.53M	$28.38	$40.49	+42.66%	Sold -0.02% shares Q3 2022
Biotechnology IVERIC bio, Inc. Portfolio share: 0.86% Portfolio value: 14.72M Avg. open price: $14.96 Current price: $23.06 P/L: +54.16% Bought +25.67% shares Q3 2022	share	0.86%	14.72M	$14.96	$23.06	+54.16%	Bought +25.67% shares Q3 2022
Drug Manufacturers—General Eli Lilly and Company Portfolio share: 0.86% Portfolio value: 14.71M Avg. open price: $166.32 Current price: $374.76 P/L: +125.32% N/A Q3 2022	share	0.86%	14.71M	$166.32	$374.76	+125.32%	N/A Q3 2022
Biotechnology Zentalis Pharmaceuticals, Inc. Portfolio share: 0.74% Portfolio value: 12.63M Avg. open price: $28.1 Current price: $21.89 P/L: -22.10% Bought +77.64% shares Q3 2022	share	0.74%	12.63M	$28.1	$21.89	-22.10%	Bought +77.64% shares Q3 2022
Biotechnology Syndax Pharmaceuticals, Inc. Portfolio share: 0.73% Portfolio value: 12.61M Avg. open price: $16.32 Current price: $25.07 P/L: +53.60% Bought +26.99% shares Q3 2022	share	0.73%	12.61M	$16.32	$25.07	+53.60%	Bought +26.99% shares Q3 2022
Medical Devices Edwards Lifesciences Corporation Portfolio share: 0.71% Portfolio value: 12.16M Avg. open price: N/A Current price: $76.55 P/L: N/A N/A Q3 2022	share	0.71%	12.16M	N/A	$76.55	N/A	N/A Q3 2022
Biotechnology Akouos, Inc. Portfolio share: 0.60% Portfolio value: 10.24M Avg. open price: $22.87 Current price: $13.29 P/L: -41.89% Bought 0.00% shares Q4 2020	share	0.60%	10.24M	$22.87	$13.29	-41.89%	Bought 0.00% shares Q4 2020
Biotechnology Arcus Biosciences, Inc. Portfolio share: 0.58% Portfolio value: 9.97M Avg. open price: N/A Current price: $35.71 P/L: N/A N/A Q3 2022	share	0.58%	9.97M	N/A	$35.71	N/A	N/A Q3 2022
Biotechnology Inozyme Pharma, Inc. Portfolio share: 0.57% Portfolio value: 9.79M Avg. open price: $4.09 Current price: $1.41 P/L: -65.53% Bought +80.21% shares Q2 2022	share	0.57%	9.79M	$4.09	$1.41	-65.53%	Bought +80.21% shares Q2 2022
Biotechnology IDEAYA Biosciences, Inc. Portfolio share: 0.57% Portfolio value: 9.76M Avg. open price: N/A Current price: $17.98 P/L: N/A N/A Q3 2022	share	0.57%	9.76M	N/A	$17.98	N/A	N/A Q3 2022
Biotechnology Travere Therapeutics, Inc. Portfolio share: 0.57% Portfolio value: 9.72M Avg. open price: $24.25 Current price: $20.08 P/L: -17.18% Bought +85.65% shares Q3 2022	share	0.57%	9.72M	$24.25	$20.08	-17.18%	Bought +85.65% shares Q3 2022
Biotechnology Prometheus Biosciences, Inc. Portfolio share: 0.48% Portfolio value: 8.24M Avg. open price: N/A Current price: $40 P/L: N/A Sold -63.83% shares Q3 2022	share	0.48%	8.24M	N/A	$40	N/A	Sold -63.83% shares Q3 2022
Biotechnology Inhibrx, Inc. Portfolio share: 0.47% Portfolio value: 8.08M Avg. open price: $21.68 Current price: $32.5 P/L: +49.93% Bought +204.31% shares Q3 2022	share	0.47%	8.08M	$21.68	$32.5	+49.93%	Bought +204.31% shares Q3 2022
Biotechnology NextCure, Inc. Portfolio share: 0.43% Portfolio value: 7.34M Avg. open price: $30.85 Current price: $1.41 P/L: -95.43% N/A Q1 2021	share	0.43%	7.34M	$30.85	$1.41	-95.43%	N/A Q1 2021
Biotechnology Adicet Bio, Inc. Portfolio share: 0.41% Portfolio value: 6.99M Avg. open price: $18.23 Current price: $19.26 P/L: +5.66% Sold -5.10% shares Q3 2022	share	0.41%	6.99M	$18.23	$19.26	+5.66%	Sold -5.10% shares Q3 2022
Biotechnology Fulcrum Therapeutics, Inc. Portfolio share: 0.38% Portfolio value: 6.45M Avg. open price: $28.21 Current price: $6.75 P/L: -76.07% N/A Q3 2022	share	0.38%	6.45M	$28.21	$6.75	-76.07%	N/A Q3 2022
Biotechnology Inhibrx, Inc. Portfolio share: 0.37% Portfolio value: 6.28M Avg. open price: $21.68 Current price: $32.5 P/L: +49.93% N/A Q3 2022	put	0.37%	6.28M	$21.68	$32.5	+49.93%	N/A Q3 2022
Biotechnology NuCana plc Portfolio share: 0.34% Portfolio value: 5.85M Avg. open price: $5.41 Current price: $0.83 P/L: -84.75% Bought +147.06% shares Q3 2020	share	0.34%	5.85M	$5.41	$0.83	-84.75%	Bought +147.06% shares Q3 2020
Biotechnology Chinook Therapeutics, Inc. Portfolio share: 0.33% Portfolio value: 5.66M Avg. open price: $17.49 Current price: $23.56 P/L: +34.71% Bought +4.08% shares Q3 2022	share	0.33%	5.66M	$17.49	$23.56	+34.71%	Bought +4.08% shares Q3 2022
Biotechnology REGENXBIO Inc. Portfolio share: 0.33% Portfolio value: 5.65M Avg. open price: $38.61 Current price: $24.26 P/L: -37.17% Sold -72.45% shares Q3 2022	share	0.33%	5.65M	$38.61	$24.26	-37.17%	Sold -72.45% shares Q3 2022
Biotechnology Galera Therapeutics, Inc. Portfolio share: 0.31% Portfolio value: 5.36M Avg. open price: N/A Current price: $1.68 P/L: N/A N/A Q4 2019	share	0.31%	5.36M	N/A	$1.68	N/A	N/A Q4 2019
Biotechnology Immatics N.V. Portfolio share: 0.31% Portfolio value: 5.32M Avg. open price: $12.44 Current price: $11.26 P/L: -9.49% Sold -58.85% shares Q3 2022	share	0.31%	5.32M	$12.44	$11.26	-9.49%	Sold -58.85% shares Q3 2022
Biotechnology Arcutis Biotherapeutics, Inc. Portfolio share: 0.30% Portfolio value: 5.24M Avg. open price: N/A Current price: $17.51 P/L: N/A N/A Q3 2022	share	0.30%	5.24M	N/A	$17.51	N/A	N/A Q3 2022
Biotechnology Agenus Inc Portfolio share: 0.29% Portfolio value: 4.99M Avg. open price: $1.94 Current price: $2.97 P/L: +53.09% Bought +155.84% shares Q3 2022	share	0.29%	4.99M	$1.94	$2.97	+53.09%	Bought +155.84% shares Q3 2022
Biotechnology Insmed Incorporated Portfolio share: 0.28% Portfolio value: 4.75M Avg. open price: $29.32 Current price: $20.37 P/L: -30.53% Bought +2894.10% shares Q3 2022	share	0.28%	4.75M	$29.32	$20.37	-30.53%	Bought +2894.10% shares Q3 2022
Biotechnology Bolt Biotherapeutics, Inc. Portfolio share: 0.24% Portfolio value: 4.07M Avg. open price: N/A Current price: $1.45 P/L: N/A N/A Q1 2021	share	0.24%	4.07M	N/A	$1.45	N/A	N/A Q1 2021
Biotechnology Geron Corporation Portfolio share: 0.16% Portfolio value: 2.78M Avg. open price: $1.37 Current price: $2.3 P/L: +67.36% Sold -57.40% shares Q3 2022	share	0.16%	2.78M	$1.37	$2.3	+67.36%	Sold -57.40% shares Q3 2022
Biotechnology Geron Corporation Portfolio share: 0.15% Portfolio value: 2.50M Avg. open price: $1.37 Current price: $2.3 P/L: +67.36% Bought +7.21% shares Q3 2022	call	0.15%	2.50M	$1.37	$2.3	+67.36%	Bought +7.21% shares Q3 2022
Biotechnology NuCana plc Portfolio share: 0.15% Portfolio value: 2.50M Avg. open price: $5.41 Current price: $0.83 P/L: -84.75% N/A Q1 2021	share	0.15%	2.50M	$5.41	$0.83	-84.75%	N/A Q1 2021
Biotechnology ImmunoGen, Inc. Portfolio share: 0.14% Portfolio value: 2.40M Avg. open price: N/A Current price: $5.47 P/L: N/A Sold -55.96% shares Q3 2022	share	0.14%	2.40M	N/A	$5.47	N/A	Sold -55.96% shares Q3 2022
Biotechnology NGM Biopharmaceuticals, Inc. Portfolio share: 0.11% Portfolio value: 1.96M Avg. open price: N/A Current price: $5.59 P/L: N/A N/A Q3 2022	call	0.11%	1.96M	N/A	$5.59	N/A	N/A Q3 2022
Biotechnology ObsEva SA Portfolio share: 0.04% Portfolio value: 675K Avg. open price: N/A Current price: $0.18 P/L: N/A N/A Q4 2018	share	0.04%	675K	N/A	$0.18	N/A	N/A Q4 2018
Biotechnology Synlogic, Inc. Portfolio share: 0.03% Portfolio value: 546K Avg. open price: N/A Current price: $0.79 P/L: N/A N/A Q4 2018	share	0.03%	546K	N/A	$0.79	N/A	N/A Q4 2018
Biotechnology PDS Biotechnology Corporation Portfolio share: 0.02% Portfolio value: 424K Avg. open price: N/A Current price: $9.78 P/L: N/A N/A Q1 2019	share	0.02%	424K	N/A	$9.78	N/A	N/A Q1 2019
Biotechnology Fusion Pharmaceuticals Inc. Portfolio share: 0.02% Portfolio value: 352K Avg. open price: $2.49 Current price: $2.27 P/L: -8.84% Bought +50.00% shares Q3 2022	share	0.02%	352K	$2.49	$2.27	-8.84%	Bought +50.00% shares Q3 2022
Biotechnology ChemoCentryx, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $37.23 Current price: $51.99 P/L: +39.66% Sold -100.00% shares Q3 2022	share	0.00%	0	$37.23	$51.99	+39.66%	Sold -100.00% shares Q3 2022
Biotechnology Amylyx Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $12.85 Current price: $39.23 P/L: +205.29% Sold -100.00% shares Q3 2022	share	0.00%	0	$12.85	$39.23	+205.29%	Sold -100.00% shares Q3 2022
Biotechnology Vertex Pharmaceuticals Incorporated Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $191.72 Current price: $321.37 P/L: +67.62% Sold -100.00% shares Q3 2022	share	0.00%	0	$191.72	$321.37	+67.62%	Sold -100.00% shares Q3 2022
Biotechnology Xencor, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $36.16 Current price: $30.86 P/L: -14.66% Sold -100.00% shares Q3 2022	share	0.00%	0	$36.16	$30.86	-14.66%	Sold -100.00% shares Q3 2022
Biotechnology ChemoCentryx, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $37.23 Current price: $51.99 P/L: +39.66% Sold -100.00% shares Q3 2022	call	0.00%	0	$37.23	$51.99	+39.66%	Sold -100.00% shares Q3 2022
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $109.35 Current price: $104.85 P/L: -4.12% Sold -100.00% shares Q3 2022	share	0.00%	0	$109.35	$104.85	-4.12%	Sold -100.00% shares Q3 2022
Biotechnology Novo Nordisk A/S Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $49.78 Current price: $126.9 P/L: +154.92% Sold -100.00% shares Q3 2022	share	0.00%	0	$49.78	$126.9	+154.92%	Sold -100.00% shares Q3 2022
SPDR S&P Biotech ETF Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $89.88 Current price: $85.66 P/L: -4.70% Sold -100.00% shares Q3 2022	put	0.00%	0	$89.88	$85.66	-4.70%	Sold -100.00% shares Q3 2022
Biotechnology Celldex Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $53.64 Current price: $37.34 P/L: -30.39% Sold -100.00% shares Q3 2022	share	0.00%	0	$53.64	$37.34	-30.39%	Sold -100.00% shares Q3 2022
Biotechnology Jounce Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $7.72 Current price: $0.9 P/L: -88.38% Sold -100.00% shares Q3 2022	share	0.00%	0	$7.72	$0.9	-88.38%	Sold -100.00% shares Q3 2022
Biotechnology argenx SE Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $402.31 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$402.31	N/A	Sold -100.00% shares Q3 2022
Biotechnology Seagen Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $122.41 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$122.41	N/A	Sold -100.00% shares Q3 2022
Biotechnology Protagonist Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $21.54 Current price: $8.07 P/L: -62.54% Sold -100.00% shares Q3 2022	call	0.00%	0	$21.54	$8.07	-62.54%	Sold -100.00% shares Q3 2022

Showing TOP 71 SOFINNOVA INVESTMENTS's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of SOFINNOVA INVESTMENTS, INC.?

The biggest position of the SOFINNOVA INVESTMENTS, INC. is Karuna Therapeutics, Inc. (KRTX) with 27.13% portfolio share worth of 466.31M US dollars.

Top 5 SOFINNOVA INVESTMENTS's holdings represent 54.22% of the portfolio:

Karuna Therapeutics, Inc. (KRTX) – 27.13%
CinCor Pharma, Inc. (CINC) – 11.61%
Natera, Inc. (NTRA) – 7.91%
Vera Therapeutics, Inc. (VERA) – 3.94%
Aerovate Therapeutics, Inc. (AVTE) – 3.63%

Who is the portfolio manager of SOFINNOVA INVESTMENTS, INC.?

The portfolio manager of the SOFINNOVA INVESTMENTS, INC. is .

What is the total asset value of the SOFINNOVA INVESTMENTS, INC. portfolio?

SOFINNOVA INVESTMENTS, INC. total asset value (portfolio value) is 1.72B US dollars.

Who is ?

is the portfolio manager of the SOFINNOVA INVESTMENTS, INC..

What is (SOFINNOVA INVESTMENTS, INC.) fund performance?

SOFINNOVA INVESTMENTS's quarterly performance is +31.77%, annualy -16.94%. In the past 3 years, the value of 's portfolio has increased by +33%.

What is the SOFINNOVA INVESTMENTS, INC. CIK?

SOFINNOVA INVESTMENTS's Central Index Key is 0001631134 .